GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
GoodRx Holdings (Nasdaq: GDRX), the leading prescription savings platform in the U.S., has announced its schedule for the release of fourth quarter and full year 2024 financial results. The company will release its financial report before U.S. markets open on Thursday, February 27, 2025.
Management will hold a conference call and webcast at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) on the same day to discuss results and business outlook. Interested parties must pre-register to access the conference call, and will receive confirmation with dial-in details and a unique passcode. The call will be webcast live on the company's investor relations website, where presentation materials will be available before the call. An archived version of the webcast will be accessible for at least 30 days after the live call.
GoodRx Holdings (Nasdaq: GDRX), la principale piattaforma di risparmio sui farmaci negli Stati Uniti, ha annunciato il suo programma per la pubblicazione dei risultati finanziari del quarto trimestre e dell'intero anno 2024. La società rilascerà il proprio rapporto finanziario prima dell'apertura dei mercati statunitensi il giovedì 27 febbraio 2025.
La direzione terrà una conference call e una webcast alle 5:00 a.m. ora del Pacifico (8:00 a.m. ora dell'Est) dello stesso giorno per discutere i risultati e le prospettive aziendali. Le parti interessate devono registrarsi in anticipo per accedere alla conference call e riceveranno una conferma con i dettagli per partecipare e un codice d'accesso unico. La call sarà trasmessa in diretta sul sito web delle relazioni con gli investitori della società, dove saranno disponibili i materiali di presentazione prima della call. Una versione archiviata della webcast sarà accessibile per almeno 30 giorni dopo la call dal vivo.
GoodRx Holdings (Nasdaq: GDRX), la principal plataforma de ahorro en recetas en EE. UU., ha anunciado su cronograma para la publicación de los resultados financieros del cuarto trimestre y del año completo 2024. La compañía publicará su informe financiero antes de la apertura del mercado estadounidense el jueves 27 de febrero de 2025.
La dirección llevará a cabo una conferencia telefónica y una transmisión en vivo a las 5:00 a.m. hora del Pacífico (8:00 a.m. hora del Este) el mismo día para discutir los resultados y las perspectivas comerciales. Las partes interesadas deben registrarse previamente para acceder a la conferencia telefónica y recibirán una confirmación con los detalles de marcación y un código de acceso único. La llamada se transmitirá en vivo en el sitio web de relaciones con inversionistas de la compañía, donde estarán disponibles los materiales de presentación antes de la llamada. Una versión archivada de la transmisión estará accesible durante al menos 30 días después de la llamada en vivo.
GoodRx Holdings (Nasdaq: GDRX), 미국의 주요 처방전 절약 플랫폼,은 2024년 4분기 및 연간 재무 결과 발표 일정을 발표했습니다. 이 회사는 2025년 2월 27일 목요일 미국 시장 개장 전에 재무 보고서를 발표할 예정입니다.
경영진은 동일한 날 태평양 표준시 기준 오전 5시 (동부 표준시 기준 오전 8시)에 결과 및 비즈니스 전망에 대해 논의하기 위해 컨퍼런스 콜과 웹캐스트를 개최합니다. 관심 있는 당사자는 컨퍼런스 콜에 접속하기 위해 사전 등록해야 하며, 접속 번호와 고유 패스코드가 포함된 확인 이메일을 받게 됩니다. 이 콜은 회사의 투자자 관계 웹사이트에서 실시간으로 방송되며, 콜 이전에 발표 자료를 제공받을 수 있습니다. 실시간 콜 후 최소 30일 동안 아카이브된 웹캐스트를 볼 수 있습니다.
GoodRx Holdings (Nasdaq: GDRX), la principale plateforme d'économies sur les prescriptions aux États-Unis, a annoncé son calendrier pour la publication des résultats financiers du quatrième trimestre et de l'ensemble de l'année 2024. La société publiera son rapport financier avant l'ouverture des marchés américains le jeudi 27 février 2025.
La direction tiendra une conférence téléphonique et un webinaire à 5h00 heure du Pacifique (8h00 heure de l'Est) ce même jour pour discuter des résultats et des perspectives commerciales. Les parties intéressées doivent s'inscrire à l'avance pour accéder à la conférence téléphonique et recevront une confirmation avec les détails d'appel et un code d'accès unique. L'appel sera diffusé en direct sur le site Web des relations avec les investisseurs de la société, où les documents de présentation seront disponibles avant l'appel. Une version archivée du webinaire sera accessible pendant au moins 30 jours après l'appel en direct.
GoodRx Holdings (Nasdaq: GDRX), die führende Plattform für Rezeptkostenersparnisse in den USA, hat ihren Zeitplan für die Veröffentlichung der finanziellen Ergebnisse des vierten Quartals und des gesamten Jahres 2024 bekannt gegeben. Das Unternehmen wird seinen Finanzbericht vor der Eröffnung der US-Märkte am Donnerstag, den 27. Februar 2025 veröffentlichen.
Die Geschäftsleitung wird am selben Tag um 5:00 Uhr Pazifische Zeit (8:00 Uhr Ostzeit) eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse und die Geschäftsausblicke zu diskutieren. Interessierte Parteien müssen sich im Voraus anmelden, um Zugriff auf die Telefonkonferenz zu erhalten, und erhalten eine Bestätigung mit Einwahldetails und einem einzigartigen Passwort. Der Anruf wird live auf der Website der Investor Relations des Unternehmens übertragen, wo Präsentationsmaterialien vor dem Anruf verfügbar sein werden. Eine archivierte Version des Webcasts wird mindestens 30 Tage nach dem Live-Anruf zugänglich sein.
- None.
- None.
To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company’s investor relations website at https://investors.goodrx.com, where accompanying materials will be posted prior to the conference call.
Approximately one hour after completion of the live call, an archived version of the webcast will be available on the Company’s investor relations website at https://investors.goodrx.com for at least 30 days.
About GoodRx
GoodRx is the leading prescription savings platform in the
GoodRx periodically posts information that may be important to investors on its investor relations website at https://investors.goodrx.com. We intend to use our website as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx’s website regularly for important information, in addition to following GoodRx’s press releases, filings with the Securities and Exchange Commission and public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx’s website is not incorporated by reference into, and is not a part of, this press release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250130275630/en/
Investor Contact
GoodRx
Aubrey Reynolds
ir@goodrx.com
Media Contact
GoodRx
Lauren Casparis
lcasparis@goodrx.com
Source: GoodRx Holdings, Inc.
FAQ
When will GoodRx (GDRX) release its Q4 and full year 2024 earnings?
What time is the GoodRx (GDRX) Q4 2024 earnings call?
How can investors access the GoodRx (GDRX) Q4 2024 earnings call?